FIVE ALARM BIO LIMITED

Five Alarm Bio is a Cambridge-based biopharma company focused on novel approaches to anti-aging, targeting an unexplored mechanism of aging to delay or prevent the onset of a broad range of age-related diseases. Founded in 2016, the company is based near Cambridge, UK, and is carrying out research at the Babraham Campus. The company is developing a small molecule approach to boost the body's defense to aging, based on a new understanding of how the chemical damage associated with age accumulates in cells. Five Alarm Bio is seeking to raise 4M to generate a pipeline of leads for high-value new medicines, including one to pre-IND stage. The company’s initial activities are focused on four diseases – Alzheimer’s, Parkinson’s, Sarcopenia and Wound Healing.